Quantcast

Latest MENLO PARK Stories

2014-07-01 12:28:07

MENLO PARK, Calif., July 1, 2014 /PRNewswire/ -- Avalanche Biotechnologies, Inc., a leader in the development of innovative gene therapies for serious eye diseases such as wet age-related macular degeneration (AMD), today announced the appointment of Samuel B. Barone, M.D. in the role of Chief Medical Officer. Dr. Barone will lead the company's clinical development programs, including advancing Avalanche's lead product, AVA-101 for the treatment of wet AMD. Dr. Barone will report to...

2014-06-24 08:39:56

Massive support from the Open Source Community, and viral demand from companies worldwide have fueled organic growth for the cloud-based continuous localization platform MENLO PARK, Calif., June 24, 2014 /PRNewswire/ -- Transifex, the worldwide localization platform that has become the premier globalization tool for tech companies and the Open Source community, announced today that they have raised $2.5 million in seed funding led by leading venture capital firm New Enterprise...

2014-05-28 08:37:09

Veteran investor goes back to entrepreneurial roots to help pilot young, focused venture firm MENLO PARK, Calif., May 28, 2014 /PRNewswire/ -- Canvas Venture Fund, a new early-stage venture capital firm formed in August 2013 with its $175 million inaugural fund, today announced that Paul Hsiao has joined the firm as a general partner and founding managing member. Mr. Hsiao is a seasoned entrepreneur, operator and venture investor. He spent the last 10 years at New Enterprise...

2014-05-20 12:33:22

MENLO PARK, Calif., May 20, 2014 /PRNewswire/ -- Avalanche Biotechnologies, Inc., a leader in the development of innovative gene therapies for serious eye diseases such as wet age-related macular degeneration (AMD), today announced the appointment of Linda C. Bain as Chief Financial Officer. With more than 20 years of finance, strategic business partner and audit experience in the biotech and pharmaceutical industries, Ms. Bain brings a distinguished track record of success, as a...

2014-05-15 23:01:01

The Dogecoin community is on its way to making "To the Moon" a reality. Team Phoenicia, Inc. and RevUp Render, Inc. have joined forces to roll out the next big Dogecoin challenge—the RevUp Render Lunar Iditarod Competition—where teams compete to have their mini rovers physically delivered and raced on the moon. Menlo Park, CA (PRWEB) May 15, 2014 "To the Moon!”—a familiar slogan that resonates in the Dogecoin community—is on its way to becoming a real-life event....

2014-04-28 08:39:24

Two pioneers of continuous delivery announce 'Agile Software Factory' program for accelerated development, testing and deployment of sites running on Oracle ATG MENLO PARK, Calif., April 28, 2013 /PRNewswire/ -- Qubell, an innovator in automated application deployment and configuration management for web-scale applications, and Grid Dynamics, the leading provider of scalable eCommerce technology solutions, today announced the launch of the Agile Software Factory (ASF) program for Oracle ATG...

2014-04-22 12:30:18

- Proceeds will Further Strengthen Avalanche's Proprietary BioFactoryTM Platform and Advance Clinical Program in Wet Age-Related Macular Degeneration - MENLO PARK, Calif., April 22, 2014 /PRNewswire/ -- Avalanche Biotechnologies, Inc, a leader in the development of innovative gene therapies for serious eye diseases such as wet age-related macular degeneration (AMD), today announced the successful completion of a $55 million Series B financing. New investors were led by Venrock, and...

2014-04-16 08:34:38

MENLO PARK, Calif., April 16, 2014 /PRNewswire/ -- ForSight VISION5 is pleased to announce it has recently closed its Series C round of funding and has also completed enrollment in its Phase 2 Clinical Study for the Helios(TM) ocular insert, its lead product candidate. ForSight VISION5 is developing non-invasive products to replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy. ForSight VISION5 has completed...

2014-03-31 08:32:29

MENLO PARK, Calif., March 31, 2014 /PRNewswire/ -- Accel-KKR, a technology-focused private equity investment firm with over $2.5 billion under management, today announced the completion of fundraising for Accel-KKR Structured Capital Partners II with $325 million in committed capital, exceeding its target. The new fund continues the predecessor fund's focus on making minority equity investments in growing technology companies via senior equity and other structured securities....

2014-03-31 08:28:22

MENLO PARK, Calif., March 31, 2014 /PRNewswire/ -- Nevro, a growth stage medical device company focused on developing innovative, evidence based solutions in the neuromodulation space, announced today the appointment of Dr. David Caraway as its Chief Medical Officer. Dr. Caraway will provide strategic direction and support the design, development, and adoption of cutting-edge therapies that aim to advance the neuromodulation field. He will also represent Nevro's mission and values in...


Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.